Kelsterbach-based opseo Gruppe provides outpatient and inpatient intensive nursing care for patients with complex needs.
Founded in 2013 in Kelsterbach, Germany, opseo Gruppe provides intensive care services for patients with complex medical needs, including respiratory support and long-term care. It operates a network of over 35 subsidiaries and more than 8,000 trained professionals. The company reported revenue of USD 315.03 mn and EBITDA of USD 54.42 mn for fiscal 2022. In June 2019 it moved from the Ergon Capital Partners III fund to the Ergon opseo Long Term Value Fund. Simon Faiß is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in